103 related articles for article (PubMed ID: 3915997)
1. Protease inhibitors of human plasma. C1-inhibitor (C1-INH).
Prograis LJ; Brickman CM; Frank MM
J Med; 1985; 16(1-3):303-50. PubMed ID: 3915997
[No Abstract] [Full Text] [Related]
2. C1-inhibitor--biochemical properties and clinical applications.
Al-Abdullah IH; Greally J
Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
[TBL] [Abstract][Full Text] [Related]
3. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
Highsmith RF; Burnett CJ; Weirich CJ
J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
[No Abstract] [Full Text] [Related]
4. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
[TBL] [Abstract][Full Text] [Related]
5. Cold enhancement of blood coagulation: observations on the role of C1(-)-inhibitor.
Donaldson VH
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():41-7. PubMed ID: 6587742
[TBL] [Abstract][Full Text] [Related]
6. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
7. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.
Wagenaar-Bos IG; Drouet C; Aygören-Pursun E; Bork K; Bucher C; Bygum A; Farkas H; Fust G; Gregorek H; Hack CE; Hickey A; Joller-Jemelka HI; Kapusta M; Kreuz W; Longhurst H; Lopez-Trascasa M; Madalinski K; Naskalski J; Nieuwenhuys E; Ponard D; Truedsson L; Varga L; Nielsen EW; Wagner E; Zingale L; Cicardi M; van Ham SM
J Immunol Methods; 2008 Sep; 338(1-2):14-20. PubMed ID: 18655790
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.
Zuraw BL; Curd JG
J Clin Invest; 1986 Aug; 78(2):567-75. PubMed ID: 3734104
[TBL] [Abstract][Full Text] [Related]
9. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.
Caliezi C; Wuillemin WA; Zeerleder S; Redondo M; Eisele B; Hack CE
Pharmacol Rev; 2000 Mar; 52(1):91-112. PubMed ID: 10699156
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary angioedema. A hereditary disorder in the synthesis of the complement system].
Vanderstock L; Vander Eecken P; Vermeersch H
Acta Otorhinolaryngol Belg; 1983; 36(3):418-31. PubMed ID: 6613563
[TBL] [Abstract][Full Text] [Related]
11. Factor VIIa in patients with C1-inhibitor deficiency.
Nielsen EW; Morrissey J; Olsen JO; Osterud B
Thromb Haemost; 1995 Oct; 74(4):1103-6. PubMed ID: 8560420
[TBL] [Abstract][Full Text] [Related]
12. C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema.
Verpy E; Couture-Tosi E; Tosi M
Behring Inst Mitt; 1993 Dec; (93):120-4. PubMed ID: 8172558
[TBL] [Abstract][Full Text] [Related]
13. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor--a still unfamiliar disease picture].
Wüthrich B; Devay J; Späth P
Schweiz Med Wochenschr; 1999 Feb; 129(7):285-91. PubMed ID: 10093876
[TBL] [Abstract][Full Text] [Related]
15. [Episodes of angioedema in children with C1 esterase inhibitor deficiency].
Strengers PF
Ned Tijdschr Geneeskd; 2006 Jul; 150(26):1480; author reply 1481. PubMed ID: 16875273
[No Abstract] [Full Text] [Related]
16. [Hereditary angioneurotic edema: a molecular disease caused by a defect in the O-glycosylation of C1 esterase inhibitor (C1-INH)].
Ollier-Hartmann MP; Strecker G; Montreuil J; Hartmann L
C R Acad Sci III; 1984; 299(16):667-9. PubMed ID: 6440668
[TBL] [Abstract][Full Text] [Related]
17. Cross-species function of the pig C1 esterase inhibitor.
Koboyashi C; Matsunami K; Omori T; Nakahata K; Nakatsu S; Xu H; Gao C; Ihara Y; Fukuzawa M; Miyagawa S
Transplant Proc; 2006 Dec; 38(10):3321-2. PubMed ID: 17175261
[TBL] [Abstract][Full Text] [Related]
18. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
Zahedi R; Wisnieski J; Davis AE
J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
[TBL] [Abstract][Full Text] [Related]
19. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
20. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
